文献速递消化、代谢与肾脏急症

电子烟联合咨询与单独咨询对戒烟效果的影响:一项随机临床试验

Effect of e-Cigarettes Plus Counseling vs Counseling Alone on Smoking Cessation: A Randomized Clinical Trial.
PubMed 文献 · JAMA · 2020-01-01
一句话结论在有意戒烟的成人中,尼古丁电子烟联合咨询较单独咨询显著提高12周时点戒断率,但24周时差异不再显著。

该随机临床试验在加拿大17个中心纳入376名有意戒烟的成人,随机分为尼古丁电子烟联合个体咨询组、非尼古丁电子烟联合咨询组和单独咨询组,电子烟使用12周。主要终点为12周时经呼出气一氧化碳生化验证的7天回忆时点戒断率,尼古丁电子烟组显著高于单独咨询组(21.9% vs 9.1%;风险差12.8,95%CI 4.0-21.6),但24周时差异不显著(17.2% vs 9.9%;风险差7.3,95%CI -1.2-15.7)。非尼古丁电子烟组12周时与单独咨询组无显著差异,24周时显著更高。不良事件常见,最常见为咳嗽和口干。试验因生产延迟提前终止,解读受限。

要点

  • 尼古丁电子烟联合咨询较单独咨询显著提高12周时点戒断率(21.9% vs 9.1%;RD 12.8,95%CI 4.0-21.6)。
  • 24周时尼古丁电子烟联合咨询与单独咨询的戒断率差异不再显著(17.2% vs 9.9%;RD 7.3,95%CI -1.2-15.7)。
  • 非尼古丁电子烟联合咨询在12周时与单独咨询无显著差异(17.3% vs 9.1%;RD 8.2,95%CI -0.1-16.6),24周时显著更高(20.5% vs 9.9%;RD 10.6,95%CI 1.8-19.4)。
  • 不良事件常见:尼古丁电子烟组94%、非尼古丁电子烟组93%、单独咨询组73%;最常见为咳嗽(64%)和口干(53%)。
  • 试验因生产延迟提前终止(376/486,77%目标样本),尼古丁与非尼古丁电子烟结果不一致,需进一步研究。

适用人群与场景

  • 纳入有意戒烟的成人,来自加拿大17个中心,2016年11月至2019年9月入组。
  • 排除标准及具体纳入条件原文未详细提及。

诊断标准与关键阈值

  • 主要终点为12周时点戒断率,采用7天回忆并经呼出气一氧化碳生化验证。
  • 缺失数据假定为继续吸烟。

处置流程与药物剂量

  • 所有组均接受个体咨询。
  • 尼古丁电子烟组(n=128)使用尼古丁电子烟12周。
  • 非尼古丁电子烟组(n=127)使用非尼古丁电子烟12周。
  • 单独咨询组(n=121)不使用电子烟。
  • 电子烟具体剂量、给药途径、频次及目标值原文未提及。

红旗征与不能漏的情况

  • 不良事件常见,最常见为咳嗽(64%)和口干(53%),需关注。
  • 严重不良事件具体信息原文未提及。

研究设计与关键结果

  • 随机临床试验,加拿大17个中心,376名有意戒烟的成人(平均年龄52岁,女性178人[47%]),随机分为尼古丁电子烟联合咨询(n=128)、非尼古丁电子烟联合咨询(n=127)和单独咨询(n=121),电子烟使用12周。
  • 主要终点12周时点戒断率:尼古丁电子烟联合咨询 vs 单独咨询为21.9% vs 9.1%(RD 12.8,95%CI 4.0-21.6),差异显著。
  • 24周时点戒断率:尼古丁电子烟联合咨询 vs 单独咨询为17.2% vs 9.9%(RD 7.3,95%CI -1.2-15.7),差异不显著。
  • 12周时点戒断率:非尼古丁电子烟联合咨询 vs 单独咨询为17.3% vs 9.1%(RD 8.2,95%CI -0.1-16.6),差异不显著。
  • 24周时点戒断率:非尼古丁电子烟联合咨询 vs 单独咨询为20.5% vs 9.9%(RD 10.6,95%CI 1.8-19.4),差异显著。
  • 不良事件:尼古丁电子烟组120例(94%),非尼古丁电子烟组118例(93%),单独咨询组88例(73%)。
  • 试验因生产延迟提前终止,实际样本376/486(77%目标样本)。

证据类型、等级与局限

  • 证据类型:随机临床试验(RCT)。
  • 局限:提前终止(样本量为目标的77%),尼古丁与非尼古丁电子烟结果不一致,缺失数据假定为吸烟,24周随访数据不完整(278/376,74%自报吸烟状态)。
  • 证据等级或推荐强度原文未提及。

对床旁实践的改变

  • 对于有意戒烟的成人,可考虑尼古丁电子烟联合个体咨询以提高短期(12周)戒断率,但长期(24周)获益不明确。
  • 非尼古丁电子烟联合咨询的短期戒断效果不显著,长期效果需进一步验证。
  • 需告知患者不良事件常见(如咳嗽、口干),并关注长期戒断维持。
  • 试验提前终止及结果不一致,临床决策需谨慎,不适用于未纳入的人群(如非有意戒烟者)。

指南或共识出处

  • 原文未提及

以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。

英文原文(摘要)· 点击展开

IMPORTANCE: Electronic cigarettes (e-cigarettes) for smoking cessation remain controversial.

OBJECTIVE: To evaluate e-cigarettes with individual counseling for smoking cessation.

DESIGN, SETTING, AND PARTICIPANTS: A randomized clinical trial enrolled adults motivated to quit smoking from November 2016 to September 2019 at 17 Canadian sites (801 individuals screened; 274 ineligible and 151 declined). Manufacturing delays resulted in early termination (376/486 participants, 77% of target). Outcomes through 24 weeks (March 2020) are reported.

INTERVENTIONS: Randomization to nicotine e-cigarettes (n = 128), nonnicotine e-cigarettes (n = 127), or no e-cigarettes (n = 121) for 12 weeks. All groups received individual counseling.

MAIN OUTCOMES AND MEASURES: The primary end point was point prevalence abstinence (7-day recall, biochemically validated using expired carbon monoxide) at 12 weeks, changed from 52 weeks following early termination. Participants missing data were assumed to be smoking. The 7 secondary end points, examined at multiple follow-ups, were point prevalence abstinence at other follow-ups, continuous abstinence, daily cigarette consumption change, serious adverse events, adverse events, dropouts due to adverse effects, and treatment adherence.

RESULTS: Among 376 randomized participants (mean age, 52 years; 178 women [47%]), 299 (80%) and 278 (74%) self-reported smoking status at 12 and 24 weeks, respectively. Point prevalence abstinence was significantly greater for nicotine e-cigarettes plus counseling vs counseling alone at 12 weeks (21.9% vs 9.1%; risk difference [RD], 12.8 [95% CI, 4.0 to 21.6]) but not 24 weeks (17.2% vs 9.9%; RD, 7.3 [95% CI, -1.2 to 15.7]). Point prevalence abstinence for nonnicotine e-cigarettes plus counseling was not significantly different from counseling alone at 12 weeks (17.3% vs 9.1%; RD, 8.2 [95% CI, -0.1 to 16.6]), but was significantly greater at 24 weeks (20.5% vs 9.9%; RD, 10.6 [95% CI, 1.8 to 19.4]). Adverse events were common (nicotine e-cigarette with counseling: 120 [94%]; nonnicotine e-cigarette with counseling: 118 [93%]; counseling only: 88 [73%]), with the most common being cough (64%) and dry mouth (53%).

CONCLUSIONS AND RELEVANCE: Among adults motivated to quit smoking, nicotine e-cigarettes plus counseling vs counseling alone significantly increased point prevalence abstinence at 12 weeks. However, the difference was no longer significant at 24 weeks, and trial interpretation is limited by early termination and inconsistent findings for nicotine and nonnicotine e-cigarettes, suggesting further research is needed.

TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT02417467.

来源:JAMA,查看原文。版权归原作者所有。

参考来源

  1. Eisenberg MJ, Hébert-Losier A, Windle SB, et al. Effect of e-Cigarettes Plus Counseling vs Counseling Alone on Smoking Cessation: A Randomized Clinical Trial. JAMA. 2020. PMID: 33170240. doi:10.1001/jama.2020.18889

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。